IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
88.80
-1.34 (-1.49%)
Apr 23, 2026, 4:00 PM EDT - Market closed
IRADIMED CORPORATION Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for IRADIMED CORPORATION stock has a target of 116, which predicts a 30.63% increase from the current stock price of 88.8.
Price Target: $116 (+30.63%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for IRADIMED CORPORATION is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Freedom Broker | Freedom Broker | Strong Buy Initiates $116 | Strong Buy | Initiates | $116 | +30.63% | Apr 2, 2026 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $60 → $72 | Strong Buy | Reiterates | $60 → $72 | -18.92% | Feb 14, 2025 |
| Roth MKM | Roth MKM | Strong Buy Maintains $65 → $60 | Strong Buy | Maintains | $65 → $60 | -32.43% | Aug 2, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | -26.80% | Apr 22, 2024 |
| Roth Capital | Roth Capital | Strong Buy Maintains $32 → $36 | Strong Buy | Maintains | $32 → $36 | -59.46% | Aug 2, 2021 |
Financial Forecast
Revenue This Year
94.19M
from 83.81M
Increased by 12.38%
Revenue Next Year
104.85M
from 94.19M
Increased by 11.31%
EPS This Year
2.12
from 1.75
Increased by 21.23%
EPS Next Year
2.37
from 2.12
Increased by 11.54%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 97.7M | 111.4M | |
| Avg | 94.2M | 104.9M | |
| Low | 89.4M | 98.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 16.5% | 18.3% | |
| Avg | 12.4% | 11.3% | |
| Low | 6.6% | 4.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.21 | 2.44 | |
| Avg | 2.12 | 2.37 | |
| Low | 2.02 | 2.27 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 26.0% | 14.8% | |
| Avg | 21.2% | 11.5% | |
| Low | 15.4% | 7.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.